Supernus Pharmaceuticals, Inc. (SUPN) Price Forecast — AI Targets | MarketCI

Supernus Pharmaceuticals, Inc. (SUPN) Price Forecast — AI Targets | MarketCI | MarketCI

SUPN

Market Closed

Supernus Pharmaceuticals, Inc.

NASDAQHealthcare Drug Manufacturers - Specialty & Generic

778 employees

CEO: Jack A. Khattar

Founded: 2012

$48.04

+$0.00(+NaN%)

Market Cap

2.79B

Beta

0.54

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Forecasting Analysis

AI-powered predictions and statistical risk modeling for short-term price movements

AI Insight:

Supernus Pharmaceuticals' AI short-term forecast indicates marginal downside risk, reflecting cautious near-term momentum. Analyst consensus shows strong coverage with tight agreement, signaling broad alignment on longer-term growth expectations. This contrast highlights potential short-term volatility against confident, unified longer-term prospects.

Current Price

N/A

Last closing price

Price Prediction

Machine learning prediction based on historical price patterns

Period:

Analyst Price Target for SUPN

Loading analyst price targets...

Wall Street Forecasts

Revenue Forecast

Past Growth

N/A

Based on Historical CAGR

Forward Growth

N/A

Projected CAGR

Analyst Accuracy

Estimate Accuracy

Revenue Analysis

Comparison of Actual and Estimated Revenues

Loading chart data...

Revenue growth steady at 0.0%.

Operating Profitability Forecast

Past Growth

N/A

EBITDA Historical CAGR

Forward Growth

N/A

EBITDA Projected CAGR

Analyst Accuracy

Estimate Accuracy

EBITDA Analysis

Comparison of Actual and Estimated EBITDA

Loading chart data...

EBITDA maintaining 0.0% trajectory.

Earnings Per Share Forecast

Past Growth

N/A

EPS Historical CAGR

Forward Growth

N/A

EPS Projected CAGR

Analyst Accuracy

Estimate Accuracy

EPS Analysis

Comparison of Actual and Estimated Earnings Per Share

Loading chart data...

EPS growth stable around 0.0%.

Explore SUPN

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

SUPN in the Healthcare

Mid Cap

Healthcare

Browse sector stocks →

Drug Manufacturers - Specialty & Generic

Browse industry stocks →